Testosterone Concentration and Incident Depression in Older Men: A Longitudinal Cohort Study
Year: 2025
Type: article
Abstract: BACKGROUND: Testosterone has been implicated in mood regulation, yet its role in the development and treatment of depression remains unclear. This study investigated the association between testosterone concentrations and the incidence of depression in older men. METHODS: We utilized data from 4 107 men aged 70 years and older who participated in the Aspirin in Reducing Events in the Elderly (ASPREE) and ASPREE-XT studies. Serum total testosterone concentrations were measured at baseline and year 3. Depressive symptoms were assessed annually using the CES-D-10 scale, with incident depression defined as a CES-D-10 score of ≥8. Cox proportional hazards regression models were used to estimate the hazard ratios (HR) for incident depression, adjusted for potential confounders. RESULTS: During a median follow-up of 8.4 years, 1 449 participants experienced an episode of depression. Baseline total testosterone concentrations were not significantly associated with the risk of incident depression, whether treated as continuous variables (HR 1.00, 95% CI 0.99-1.01) or when categorized into quintiles. Similarly, changes in testosterone concentrations from baseline to year 3 did not predict incident depression (aHR 1.03, 95% CI 0.99-1.08). A subgroup analysis focusing on men with biochemical evidence of hypogonadism also found no association with incident depression. CONCLUSIONS: Our findings do not support an association between testosterone concentrations and the risk of developing depression in older men. These results suggest that testosterone is not an important factor in the pathogenesis of depression in this population. There may still be individual variability in response to testosterone changes and its potential impact on mood disorders.
Authors: Malcolm Forbes, Mojtaba Lotfaliany, Cammie Tran, Mohammadreza Mohebbi, Robyn L Woods, John J McNeil, Michael Berk
Institutions: Deakin University, Monash University
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,408
Awards: G13697443, G1740950978, G2519376027, G313601605, G4832227944, Novel therapies for psychiatric disorders, ASPREE Completion Project, G6485832292, G713793082, G7210608478, G8586009266, G8718603654, ASPREE-D; Aspirin in the prevention of depression in the elderly, ASPirin in Reducing Events in the Elderly (ASPREE), G9000088779, G9000156609
OpenAlex ID: W4407426879
